This is a past event. Registration is closed. View other AmCham China events.
Roberta Lipson
Co-Chair of AmCham China Healthcare Forum; CEO at United Family HealthcareRoberta Lipson is the Co-Chair of AmCham China Healthcare Forum, CEO and founder of United Family Healthcare (UFH). She has over 40 years of experience as a pioneer in the healthcare industry in China. She originally co-founded United Family Healthcare’s predecessor company Chindex in 1981, expanding the business from China’s top medical equipment distribution company into China’s first and largest foreign-invested healthcare system. After almost two decades, UFH has established itself with hospitals and clinics in Beijing, Shanghai, Guangzhou, Tianjin, Qingdao, and Hangzhou as the provider of choice for those seeking premium, personalized healthcare. United Family Healthcare was rated in 2016 as “The Most Trusted Healthcare Brand of China” by the Chinese Business Journal.
Ms. Lipson is an active leader in the business community in Beijing, having served as a director of the U.S. China Business Council, as well as 4 successive terms on the Board of Governors of the American Chamber of Commerce in China (AmCham), and as Co-Chair of the AmCham Healthcare Forum. She also chairs the Board of the United Foundation for China’s Health (UFCH), and is a co- founder of Beijing’s Jewish Community - Kehillat Beijing. Because of her outstanding contribution in China, Roberta Lipson received “The Great Wall Friendship Reward” in 2009, the highest honor that Beijing government gives to foreign experts in Beijing. In 2014 Roberta was honored by AmCham as the inaugural recipient of the China Pioneer Award. She was named as a “Top 10 Business Leader of China” by Sina.com in 2015, and earlier she led the company to win the U.S. State Department ACE Award for Corporate Excellence. With 40 years living and working in Beijing, in 2017 Ms. Lipson received Foreign Permanent Resident Card. Ms. Lipson holds a BA from Brandeis University and an MBA from Columbia University.
Prof. Kevin D. Frick
Professor and Vice Dean for Education at Johns Hopkins University Carey Business SchoolKevin Frick is a health economist and a Professor and the Vice Dean for Education at the Johns Hopkins Carey Business School. He has participated in research with collaborators from across many divisions within the University and around the world focusing largely on the cost of various health conditions and the cost-effectiveness of treating those conditions. His most frequent clinical area of focus is eye care—studying its economic and quality of life impact as well as the cost-effectiveness of specific treatments and the business model for screening for and treatment of conditions. His love of teaching was exemplified by his receipt of two Golden Apple awards when he was with the Bloomberg School of Public Health, another division of the University. He has guest lectured at the Bloomberg School of Public Health, the School of Nursing, and for the University’s Center for Talented Youth. Within the Carey Business School, he has taught health care financing and economics for managerial decision making and now teaching a course called Frameworks for Analyzing Health Care Markets. He has also lectured about economics and health at universities across the country and around the world. He has played an integral role in the school’s transition to more online teaching over time, and his role at the School includes overseeing all student-related activities (such as admission, academic programs, advising, records and registration, career development, student affairs, experiential learning, integrated learning, and financial aid management) as well as the Office of Institutional Data and Analytics.
Christopher Hickey Ph.D
Senior Director, Emerging Markets Policy, Asia Pacific of PfizerSince 2015, Dr. Christopher Hickey has served as Senior Director, Emerging Markets Policy, Asia-Pacific for Pfizer. Posted in Beijing, Dr. Hickey provides above-market support for and leadership of Pfizer’s engagement of key external stakeholders in Asia. In
support of key objectives across Pfizer’s business, he formulates and implements strategy for Pfizer’s interface with key government agencies, civil society stakeholders, academic and public health experts, and other key players.
Before joining Pfizer, Dr. Hickey served from 2008 to 2015 as the Country Director for the U.S. Food and Drug Administration (FDA) for the People’s Republic of China. FDA’s first-ever overseas assignee, Dr. Hickey was a trailblazer who helped FDA to shape and form its overseas operations in China and beyond. In the latter years of his FDA China role, he spearheaded the dramatic expansion of FDA’s staffing in China though complex, long-term diplomatic negotiations with the Chinese Government.
From 2004 to 2008, Dr. Hickey served in the Office of Global Health Affairs within the Office of the Secretary at the U.S. Department of Health and Human Services (HHS). In that capacity, he held responsibility for a range of health-related policy issues and programmatic initiatives, first in multilateral affairs, and then in Asia and the Pacific Rim. At HHS, Dr. Hickey played a key role in the negotiation of the WHO International Health Regulations, the UN Convention on the Rights of Persons with Disabilities, and product-safety agreements with China’s State Food and Drug Administration and General Administration of Quality Supervision, Inspection and Quarantine.
Dr. Hickey also served from 2002 to 2004 as Vice President for Education and Research at the Institute for Global Engagement, a Philadelphia-based human rights NGO, and as an independent consultant in Kyiv, Ukraine from 2000 to 2002. He earned his Ph.D. in sociology from the University of Virginia in 2002, his M.A. in sociology from the University of Illinois, Urbana-Champaign in 1994, and his B.A. summa cum laude in American Studies and Spanish from Franklin College of Indiana in 1992.
Dr. Hickey lives in Beijing with his wife and daughter.